Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsector:
Small molecules
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Cardiovascular / cardiology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 15
Description:
Nanjing TransThera Biosciences Co., Ltd. is mainly engaged in the research and development of small molecule innovative drugs for global markets. The company currently owns an independent R&D site of 1800 square meters. The company is establishing a series of complete innovative drug research and development system. TransThera focuses on the development of novel therapeutics for cancer, cardiovascular and inflammatory diseases.
